BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37817707)

  • 1. Potassium Voltage-Gated Channel Subfamily H Member 1 (KCNH1) Missense Mutation Causing Epileptic Encephalopathy And Autistic Behaviour.
    Chand P; Sulaiman A; Kirmani S
    J Pak Med Assoc; 2023 Sep; 73(9):1894-1896. PubMed ID: 37817707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temple-Baraitser Syndrome and Zimmermann-Laband Syndrome: one clinical entity?
    Mégarbané A; Al-Ali R; Choucair N; Lek M; Wang E; Ladjimi M; Rose CM; Hobeika R; Macary Y; Temanni R; Jithesh PV; Chouchane A; Sastry KS; Thomas R; Tomei S; Liu W; Marincola FM; MacArthur D; Chouchane L
    BMC Med Genet; 2016 Jun; 17(1):42. PubMed ID: 27282200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Splitting versus lumping': Temple-Baraitser and Zimmermann-Laband Syndromes.
    Bramswig NC; Ockeloen CW; Czeschik JC; van Essen AJ; Pfundt R; Smeitink J; Poll-The BT; Engels H; Strom TM; Wieczorek D; Kleefstra T; Lüdecke HJ
    Hum Genet; 2015 Oct; 134(10):1089-97. PubMed ID: 26264464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potassium Channel KCNH1 Activating Variants Cause Altered Functional and Morphological Ciliogenesis.
    Napoli G; Panzironi N; Traversa A; Catalanotto C; Pace V; Petrizzelli F; Giovannetti A; Lazzari S; Cogoni C; Tartaglia M; Carella M; Mazza T; Pizzuti A; Parisi C; Caputo V
    Mol Neurobiol; 2022 Aug; 59(8):4825-4838. PubMed ID: 35639255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in KCNH1 and ATP6V1B2 cause Zimmermann-Laband syndrome.
    Kortüm F; Caputo V; Bauer CK; Stella L; Ciolfi A; Alawi M; Bocchinfuso G; Flex E; Paolacci S; Dentici ML; Grammatico P; Korenke GC; Leuzzi V; Mowat D; Nair LD; Nguyen TT; Thierry P; White SM; Dallapiccola B; Pizzuti A; Campeau PM; Tartaglia M; Kutsche K
    Nat Genet; 2015 Jun; 47(6):661-7. PubMed ID: 25915598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic expansion of KCNH1-associated disorders to include isolated epilepsy and its associations with genotypes and molecular sub-regional locations.
    Tian MQ; Li RK; Yang F; Shu XM; Li J; Chen J; Peng LY; Yu XH; Yang CJ
    CNS Neurosci Ther; 2023 Jan; 29(1):270-281. PubMed ID: 36285361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo KCNH1 mutations in four patients with syndromic developmental delay, hypotonia and seizures.
    Fukai R; Saitsu H; Tsurusaki Y; Sakai Y; Haginoya K; Takahashi K; Hubshman MW; Okamoto N; Nakashima M; Tanaka F; Miyake N; Matsumoto N
    J Hum Genet; 2016 May; 61(5):381-7. PubMed ID: 26818738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with
    Aubert Mucca M; Patat O; Whalen S; Arnaud L; Barcia G; Buratti J; Cogné B; Doummar D; Karsenty C; Kenis S; Leguern E; Lesca G; Nava C; Nizon M; Piton A; Valence S; Villard L; Weckhuysen S; Keren B; Mignot C
    J Med Genet; 2022 May; 59(5):505-510. PubMed ID: 33811134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epilepsy in KCNH1-related syndromes.
    Mastrangelo M; Scheffer IE; Bramswig NC; Nair LD; Myers CT; Dentici ML; Korenke GC; Schoch K; Campeau PM; White SM; Shashi V; Kansagra S; Van Essen AJ; Leuzzi V
    Epileptic Disord; 2016 Jun; 18(2):123-36. PubMed ID: 27267311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syndromic disorders caused by gain-of-function variants in KCNH1, KCNK4, and KCNN3-a subgroup of K
    Gripp KW; Smithson SF; Scurr IJ; Baptista J; Majumdar A; Pierre G; Williams M; Henderson LB; Wentzensen IM; McLaughlin H; Leeuwen L; Simon MEH; van Binsbergen E; Dinulos MBP; Kaplan JD; McRae A; Superti-Furga A; Good JM; Kutsche K
    Eur J Hum Genet; 2021 Sep; 29(9):1384-1395. PubMed ID: 33594261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the voltage-gated potassium channel gene KCNH1 cause Temple-Baraitser syndrome and epilepsy.
    Simons C; Rash LD; Crawford J; Ma L; Cristofori-Armstrong B; Miller D; Ru K; Baillie GJ; Alanay Y; Jacquinet A; Debray FG; Verloes A; Shen J; Yesil G; Guler S; Yuksel A; Cleary JG; Grimmond SM; McGaughran J; King GF; Gabbett MT; Taft RJ
    Nat Genet; 2015 Jan; 47(1):73-7. PubMed ID: 25420144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and characterization of ZJUCHi003: an induced pluripotent stem cell line from a patient with Temple-Baraitser/Zimmermann-Laband syndrome carrying KCNH1 c.1070G > A (p.R357Q) variant.
    Chen D; Su J; Huang X; Chen H; Jiang T; Zhi C; Zhou Z; Zhang B; Yu L; Jiang X
    Hum Cell; 2024 May; 37(3):832-839. PubMed ID: 38372889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temple-Baraitser syndrome with KCNH1 Asn510Thr: a new case report.
    Wang H; Zhang X; Ding H
    Clin Dysmorphol; 2021 Jan; 30(1):27-31. PubMed ID: 32956079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cantú syndrome versus Zimmermann-Laband syndrome: Report of nine individuals with ABCC9 variants.
    Kortüm F; Niceta M; Magliozzi M; Dumic Kubat K; Robertson SP; Moresco A; Dentici ML; Baban A; Leoni C; Onesimo R; Obregon MG; Digilio MC; Zampino G; Novelli A; Tartaglia M; Kutsche K
    Eur J Med Genet; 2020 Sep; 63(9):103996. PubMed ID: 32622958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel
    von Wrede R; Jeub M; Ariöz I; Elger CE; von Voss H; Klein HG; Becker AJ; Schoch S; Surges R; Kunz WS
    Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33494179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gain-of-Function Mutations in KCNN3 Encoding the Small-Conductance Ca
    Bauer CK; Schneeberger PE; Kortüm F; Altmüller J; Santos-Simarro F; Baker L; Keller-Ramey J; White SM; Campeau PM; Gripp KW; Kutsche K
    Am J Hum Genet; 2019 Jun; 104(6):1139-1157. PubMed ID: 31155282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is KCNH1 mutation related to coronary artery ectasia.
    Noori MR; Zhang B; Pan L
    BMC Cardiovasc Disord; 2019 Dec; 19(1):296. PubMed ID: 31847810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kv10.1 potassium channel: from the brain to the tumors.
    Cázares-Ordoñez V; Pardo LA
    Biochem Cell Biol; 2017 Oct; 95(5):531-536. PubMed ID: 28708947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism.
    Kim HG; Rosenfeld JA; Scott DA; Bénédicte G; Labonne JD; Brown J; McGuire M; Mahida S; Naidu S; Gutierrez J; Lesca G; des Portes V; Bruel AL; Sorlin A; Xia F; Capri Y; Muller E; McKnight D; Torti E; Rüschendorf F; Hummel O; Islam Z; Kolatkar PR; Layman LC; Ryu D; Kong IK; Madan-Khetarpal S; Kim CH
    Mol Autism; 2019; 10():35. PubMed ID: 31649809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual Molecular Effects of Dominant RORA Mutations Cause Two Variants of Syndromic Intellectual Disability with Either Autism or Cerebellar Ataxia.
    Guissart C; Latypova X; Rollier P; Khan TN; Stamberger H; McWalter K; Cho MT; Kjaergaard S; Weckhuysen S; Lesca G; Besnard T; Õunap K; Schema L; Chiocchetti AG; McDonald M; de Bellescize J; Vincent M; Van Esch H; Sattler S; Forghani I; Thiffault I; Freitag CM; Barbouth DS; Cadieux-Dion M; Willaert R; Guillen Sacoto MJ; Safina NP; Dubourg C; Grote L; Carré W; Saunders C; Pajusalu S; Farrow E; Boland A; Karlowicz DH; Deleuze JF; Wojcik MH; Pressman R; Isidor B; Vogels A; Van Paesschen W; Al-Gazali L; Al Shamsi AM; Claustres M; Pujol A; Sanders SJ; Rivier F; Leboucq N; Cogné B; Sasorith S; Sanlaville D; Retterer K; Odent S; Katsanis N; Bézieau S; Koenig M; Davis EE; Pasquier L; Küry S
    Am J Hum Genet; 2018 May; 102(5):744-759. PubMed ID: 29656859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.